Kase, N., Terashima, M., Ohta, A., Niwa, A., Honda‐Ozaki, F., Kawasaki, Y., . . . Saito, M. K. (2020). Pluripotent stem cell‐based screening identifies CUDC‐907 as an effective compound for restoring the in vitro phenotype of Nakajo‐Nishimura syndrome. Stem Cells Transl Med.

Kase, Naoya, Madoka Terashima, Akira Ohta, Akira Niwa, Fumiko Honda‐Ozaki, Yuri Kawasaki, Tatsutoshi Nakahata, Nobuo Kanazawa, et Megumu K. Saito. "Pluripotent Stem Cell‐based Screening Identifies CUDC‐907 As an Effective Compound for Restoring the in Vitro Phenotype of Nakajo‐Nishimura Syndrome." Stem Cells Transl Med 2020.

Kase, Naoya, et al. "Pluripotent Stem Cell‐based Screening Identifies CUDC‐907 As an Effective Compound for Restoring the in Vitro Phenotype of Nakajo‐Nishimura Syndrome." Stem Cells Transl Med 2020.